Related Experiment Videos
Innovative treatment approaches for rheumatoid arthritis. New cyclo-oxygenase and cytokine inhibitors
1Department of Rheumatology and Rehabilitation, University of Leeds, UK.
Abstract:
A need remains for the development of more effective therapies for the treatment of rheumatoid arthritis (both NSAIDs and DMARDs). The NSAIDs remain the cornerstone of symptomatic therapy, but concern remains about their safety, potential for the delay in commencing definitive therapy and theoretical pro-inflammatory effects. Each of the NSAIDs reviewed here do provide an advantage over therapies previously available and should prove to be useful additions to the rheumatologists' therapeutic armament.
Insights
New non-steroidal anti-inflammatory drugs (NSAIDs) offer improved symptomatic relief for rheumatoid arthritis. While concerns about safety and delayed treatment persist, these NSAIDs represent valuable additions to rheumatologists' therapeutic options.
Area of Science:
- Rheumatology
- Pharmacology
Background:
- Rheumatoid arthritis treatment requires more effective therapies beyond current non-steroidal anti-inflammatory drugs (NSAIDs) and disease-modifying antirheumatic drugs (DMARDs).
- NSAIDs are foundational for symptomatic relief in rheumatoid arthritis, but safety concerns and potential pro-inflammatory effects necessitate careful consideration.
- The risk of delaying definitive treatment with NSAIDs is a significant clinical challenge.
Purpose of the Study:
- To review current non-steroidal anti-inflammatory drugs (NSAIDs) for rheumatoid arthritis management.
- To evaluate the advantages of newly available NSAIDs compared to existing therapies.
- To assess the role of NSAIDs in the broader context of rheumatoid arthritis treatment strategies.
Main Methods:
- Review of existing literature on NSAIDs for rheumatoid arthritis.
- Analysis of safety profiles and efficacy data for selected NSAIDs.
- Comparison of NSAIDs with other available rheumatoid arthritis treatments.
Main Results:
- The reviewed NSAIDs demonstrate advantages over previously available therapeutic options.
- These NSAIDs are considered useful additions to the rheumatologist's toolkit for managing rheumatoid arthritis symptoms.
- Despite advantages, concerns regarding NSAID safety and impact on definitive therapy initiation remain relevant.
Conclusions:
- Newer NSAIDs provide valuable symptomatic treatment options for rheumatoid arthritis.
- Rheumatologists can consider these agents as beneficial additions to their therapeutic armamentarium.
- Ongoing vigilance regarding NSAID safety and treatment sequencing is crucial for optimal rheumatoid arthritis care.